Structure |
Chemical Name |
CAS |
MF |
 |
Amifostine Impurity 7 |
174397-83-2 |
C7H16Br2N2 |
 |
Bendamustine Impurity 31 |
|
|
 |
Carbidopa Impurity 2 |
1361017-74-4 |
C11H16N2O4 |
 |
Cefazolin Impurity 2 |
|
|
 |
Cefminox Sodium Impurity 8 |
|
|
 |
Dapagliflozin Impurity 28 |
|
|
 |
Erlotinib Impurity 51 |
115665-66-2 |
C8H6BrNO2 |
 |
Oseltamivir Impurity 18 |
|
|
 |
Plerixafor Impurity 6 |
|
|
 |
Pregabalin Impurity 49 |
1568110-05-3 |
C10H21NO2 |
 |
Rivaroxaban Impurity 79 |
1642601-00-0 |
C38H38N4O12 |
 |
Rocuronium Bromide Impurity 37 |
|
|
 |
Rosuvastatin Impurity 4 |
1899869-35-2 |
C19H22FN3O3S |
 |
5-Methyl-3-phenylisoxazole-4-carboxylic acid |
1136-45-4 |
C11H9NO3 |
 |
Bendamustine Impurity 26 |
|
|
 |
Canagliflozin Impurity 26 |
|
|
 |
Edoxaban Impurity 37 |
2081883-50-1 |
C14H27N3O3 |
 |
Imatinib Impurity 10 |
|
|
![(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid](/CAS/20180629/GIF/1012341-54-6.gif) |
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-54-6 |
C23H29NO4 |
![Calcium bis[4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-3-methyl-4-oxo-4-(propan-2-yloxyl)butyl]amino}-4-oxobutanoate]](/CAS/20180629/GIF/CB02995780.gif) |
Calcium bis[4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-3-methyl-4-oxo-4-(propan-2-yloxyl)butyl]amino}-4-oxobutanoate] |
|
C50H60CaN2O10 |
 |
3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzamide |
917391-28-7 |
C12H10F3N3O |
 |
Alogliptin Impurity E |
|
|
 |
Alogliptin Impurity E |
|
|
![Carbamic acid, N-[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]-, 1,1-dimethylethyl ester](/CAS/20180629/GIF/830346-51-5.gif) |
Carbamic acid, N-[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]-, 1,1-dimethylethyl ester |
830346-51-5 |
C33H32F5N3O5 |
 |
Baicalein 6-O-glucoside |
28279-72-3 |
C21H20O10 |
 |
Levofloxacin Impurity 19 |
|
C18H20FN3O4 |
 |
Olanzapine Impurity K |
|
C17H20N4S |
 |
Ticagrelor Related Compound 55 |
|
|
 |
Ticagrelor Related Compound 73 |
|
|
 |
Vildagliptin Impurity 10 |
|
|
 |
Cefaclor Impurity 2 |
722547-49-1 |
C17H18N2O3 |
 |
Cefodizime Impurity F |
|
|
 |
Olaparib Impurity F |
|
|
 |
Ornidazole Impurity G |
|
|
 |
Pidotimod Impurity L |
|
|
 |
Tadalafil Impuirty 20 |
2924098-58-6 |
|
 |
Tenofovir Impurity 53 |
|
|
 |
(S)-3-(4-benzylphenoxy)tetrahydrofuran |
|
C17H18O2 |
 |
Ampicillin |
1207726-28-0 |
C24H26N4O5S |
 |
ethyl 2-(4-(sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-
carboxylate |
2375033-35-3 |
C18H20N2O3S |
 |
(S)-Indacaterol |
1384188-70-8 |
C24H29ClN2O3 |
 |
Aripiprazole Impurity 47 |
2250242-47-6 |
C27H33Cl2N3O3 |
 |
Aripiprazole Impurity 47 |
2250242-47-6 |
C27H33Cl2N3O3 |
 |
Cefminox Sodium Impurity 3 |
1420072-83-8 |
C16H21N7O6S4 |
 |
Edaravone Impurity 26 |
152494-76-3 |
|
 |
Levofloxacin Impurity 24 |
|
C18H20FN3O4 |
 |
Parecoxib N-Oxide |
|
|
 |
Rosuvastatin Impurity 84 |
|
|
 |
Timolol EP Impurity I |
|
|
 |
172967-64-5 |
172967-64-5 |
C18H16ClNO3 |
 |
Pregabalin Impurity PD0224377 |
501665-97-0 |
C14H25NO6 |
 |
Nintedanib Impurity 24 |
|
|
![2-(((3,4-dimethoxypyridin-2-yl)methyl)thio)-1H-benzo[d]
imidazol-5-ol](/CAS/20200119/GIF/1166386-02-2.gif) |
2-(((3,4-dimethoxypyridin-2-yl)methyl)thio)-1H-benzo[d]
imidazol-5-ol |
1166386-02-2 |
C15H15N3O3S |
 |
N-((2-(5-methyl-4-phenylisoxazol-3-yl)phenyl)sulfonyl)propionamide |
2304623-38-7 |
C19H18N2O4S |
 |
RocuroniuMbroMide iMpurity B |
|
|
 |
TetrazepaM IMp. C (EP): 7-Chloro-5-cyclohexyl-1-Methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
|
|
 |
bis(2-(7-Methoxynaphthalen-1-yl)ethyl)aMine |
1623104-92-6 |
C26H28ClNO2 |
 |
bis(2-(7-Methoxynaphthalen-1-yl)ethyl)aMine |
1623104-92-6 |
C26H28ClNO2 |
![Methyl 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate](/CAS/20130318/GIF/CB02611251.gif) |
Methyl 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate |
1403474-78-1 |
C24H18N4O5 |
 |
Thiazolylacetyl glycine oxiMe |
178949-03-6 |
C7H8N4O4S |
 |
3-O-Decladinosyl-6-O-Methylerythronolide A |
118058-74-5 |
C30H55NO10 |
 |
Desmethyl Ranolazine |
755711-09-2 |
C23H31N3O3 |
![P-[[(1S)-2-(6-AMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-phosphonic Acid Monoethyl Ester](/CAS/GIF/1255525-18-8.gif) |
P-[[(1S)-2-(6-AMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-phosphonic Acid Monoethyl Ester |
1255525-18-8 |
C11H18N5O4P |
![8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane BroMide](/CAS/GIF/795313-24-5.gif) |
8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane BroMide |
795313-24-5 |
C14H19BrCl2N2 |
![8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane BroMide](/CAS/GIF/795313-24-5.gif) |
8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane BroMide |
795313-24-5 |
C14H19BrCl2N2 |
 |
9-MethoxyMethyl Guanine |
1202645-50-8 |
C7H9N5O2 |
 |
ClindaMycin 3-PalMitate |
68225-59-2 |
C34H63ClN2O6S |
 |
EltroMbopag Methyl Ester |
1246929-01-0 |
C26H24N4O4 |
 |
ErythroMycin A 6,9-IMino Ether |
99290-97-8 |
C37H66N2O12 |
![α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol](/CAS/GIF/333749-57-8.gif) |
α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol |
333749-57-8 |
C24H34N2O6 |
 |
Ticagrelor IMpurity E |
1402150-34-8 |
C26H30F2N6O5S |
![Benzenebutanoicacid,b-[[(1,1-diMethylethoxy)carbonyl]aMino]-2,4,5-trifluoro-,Methylester,(bR)-](/CAS/20150408/GIF/881995-73-9.gif) |
Benzenebutanoicacid,b-[[(1,1-diMethylethoxy)carbonyl]aMino]-2,4,5-trifluoro-,Methylester,(bR)- |
881995-73-9 |
C16H20F3NO4 |
 |
Bosutinib Impurity 1 |
1460227-29-5 |
C18H13Cl2N3O3 |
 |
S,S-Efinaconazole |
164650-45-7 |
C18H22F2N4O |
 |
BendaMustine IMpurity |
|
|
![Acetic acid, 2-chloro-2-[2-(2-Methoxyphenyl)hydrazinylidene]-, ethyl ester](/CAS/20150408/GIF/85014-68-2.gif) |
Acetic acid, 2-chloro-2-[2-(2-Methoxyphenyl)hydrazinylidene]-, ethyl ester |
85014-68-2 |
C11H13ClN2O3 |
![D-Alanine, N-[[P(S),2'R]-2'-cyano-2'-deoxy-2'-Methyl-P-phenyl-5'-cytidylyl]-, 1-Methylethyl ester](/CAS/20180808/GIF/1496552-28-3.gif) |
D-Alanine, N-[[P(S),2'R]-2'-cyano-2'-deoxy-2'-Methyl-P-phenyl-5'-cytidylyl]-, 1-Methylethyl ester |
1496552-28-3 |
C22H29FN3O9P |
![D-Glucitol, 1,5-anhydro-1-C-[4-Methyl-3-[(5-phenyl-2-thienyl)Methyl]phenyl]-, (1S)-](/CAS/20180906/GIF/842133-16-8.gif) |
D-Glucitol, 1,5-anhydro-1-C-[4-Methyl-3-[(5-phenyl-2-thienyl)Methyl]phenyl]-, (1S)- |
842133-16-8 |
C24H26O5S |
 |
Phthalic acid, 3,3'-azoxydi- (8CI) |
22895-28-9 |
C16H10N2O9 |
![(alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile](/CAS/20150408/GIF/1150310-15-8.gif) |
(alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile |
1150310-15-8 |
C15H15N3O5 |
 |
(2E)-2-Cyano-3-(3-ethoxy-4-hydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide |
857629-79-9 |
C16H19N3O5 |
![(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate](/CAS/20150408/GIF/149709-59-1.gif) |
(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate |
149709-59-1 |
C25H31NO4 |
 |
1-(3-AMinopropyl)-4-(2-Methoxyphenyl)piperazine 97% |
20529-23-1 |
C14H23N3O |
 |
(R)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
404874-94-8 |
C20H20FNO4 |
 |
(S)-3-((S)-5-hydroxy-5-phenylpentanoyl)-4-phenyloxazolidin-2-one |
|
C20H21NO4 |
 |
Apixaban Impurity 20 |
1421823-20-2 |
C27H29ClN4O5 |
 |
Posaconazole iMpurity 4 |
2125944-53-6 |
C30H35N5O3 |
 |
Everolimus Ring-Opening Impurity |
1708118-13-1 |
C53H83NO14 |
 |
Topiroxostat Impurity 6 |
2044704-63-2 |
C7H8N4O2 |
 |
Dienogest Impurity I |
65928-65-6 |
C20H27NO2 |
 |
Febuxostat Impurity 8 |
144060-62-8 |
C16H17NO4S |
 |
Lornoxicam Impurity 9 |
70374-36-6 |
C6H6ClNO4S2 |
 |
Ticagrelor Related Compound 3 |
88756-83-6 |
C8H15NO3 |
 |
135270-10-9 |
135270-10-9 |
C12H11F2N3O |
 |
Tadalafil EP Impurity |
479545-76-1 |
C21H16N2O5 |
 |
Vonoprazan Impurity C |
|
|
 |
(5RS)-5-Ethyl-2,6-diimino-5-phenyl-1,2,5,6-tetrahydropyrimidin-4(3H)-one |
69125-70-8 |
C12H14N4O |
 |
(2S,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol |
135272-36-5 |
C12H13F2N3O2 |
![Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl-](/CAS/20180629/GIF/132810-75-4.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl- |
132810-75-4 |
C23H31N3 |
![(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one](/CAS/20180629/GIF/1839099-22-7.gif) |
(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one |
1839099-22-7 |
C25H26N6O2 |